Filter News
Area of Research
News Type
News Topics
- (-) Bioenergy (1)
- (-) Biomedical (2)
- (-) Computer Science (2)
- (-) Environment (1)
- (-) Security (1)
- 3-D Printing/Advanced Manufacturing (1)
- Advanced Reactors (1)
- Artificial Intelligence (1)
- Composites (1)
- Cybersecurity (1)
- Isotopes (1)
- Machine Learning (1)
- Neutron Science (8)
- Nuclear Energy (2)
- Physics (2)
Media Contacts
An international team of scientists, led by the University of Manchester, has developed a metal-organic framework, or MOF, material
Oak Ridge National Laboratory will give college students the chance to practice cybersecurity skills in a real-world setting as a host of the Department of Energy’s fifth collegiate CyberForce Competition on Nov. 16. The event brings together student teams from across the country to compete at 10 of DOE’s national laboratories.
IDEMIA Identity & Security USA has licensed an advanced optical array developed at Oak Ridge National Laboratory. The portable technology can be used to help identify individuals in challenging outdoor conditions.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
Scientists at the Department of Energy’s Oak Ridge National Laboratory have created a recipe for a renewable 3D printing feedstock that could spur a profitable new use for an intractable biorefinery byproduct: lignin.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.